Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
TEVA | Tel Aviv | ILS | Delayed | |
TEVA | NYSE | USD | Real-time | |
TEVAN | Mexico | MXN | Delayed | |
TEVAy | TradeGate | EUR | Delayed | |
T1EV34 | B3 | BRL | Delayed | |
TEVAg | Vienna | EUR | Real-time |
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin’s lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington’s disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
Name | Age | Since | Title |
---|---|---|---|
Sol J. Barer | 75 | 2015 | Independent Chairman of the Board |
Amir Elstein | 67 | 2005 | Independent Director |
Roberto Agostino Mignone | 51 | 2017 | Independent Director |
Rosemary A. Crane | 63 | 2015 | Independent Director |
Gerald M. Lieberman | 76 | 2015 | Independent Director |
Perry D. Nisen | 67 | 2017 | Independent Director |
Ronit Satchi-Fainaro | 51 | 2018 | Independent Director |
Varda Shalev | 63 | 2023 | Independent Director |
Richard D. Francis | 56 | 2023 | President, CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review